The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Can grade 2 neutropenia predict the risk of grade 3 neutropenia in metastatic colorectal cancer patients treated with chemotherapy?
Yoichiro Yoshida
No relevant relationships to disclose
Seiichiro Hoshino
No relevant relationships to disclose
Naoya Aisu
No relevant relationships to disclose
Masayasu Naito
No relevant relationships to disclose
Syu Tanimura
No relevant relationships to disclose
Yuichi Yamashita
No relevant relationships to disclose